-- Project funded through CQDM Quantum Leap program -- Montréal, QUÉBEC, November 11th, 2025 – CQDM and Saguaro Biosciences are proud to announce that the company has received more than $780,000 to further enhance ChromaLIVETM,...

October 15th, 2025. QUEBEC CITY--(BUSINESS WIRE)--Saguaro Biosciences, a pioneer in non-toxic live cell reagents for enhanced drug insights, announces a new distribution agreement with Bio-Techne Corporation (NASDAQ:TECH), a global provider of life science tools, reagents...

June 04th, 2024. QUEBEC CITY--(BUSINESS WIRE)--Saguaro Biosciences, a pioneering developer of live cell reagents for AI-enhanced discoveries, today announced the successful closing of a $3 million seed funding round, comprised of equity investments and non-dilutive...

November 17th, 2022. QUEBEC CITY & TOKYO--(BUSINESS WIRE)--Saguaro Technologies inc., a cell culture product company that offers a first-of-a-kind dye technology, and Funakoshi Co., Ltd., a top Japanese distributor of life science reagents and products,...

March 23rd, 2022. QUEBEC CITY (NEWS WIRE) Bringing new biology to light! QUÉBEC CITY, March 23, 2022 /CNW/ - Saguaro Technologies inc. announces today an exclusive worldwide license agreement with Sunnybrook Research Institute (SRI) on small molecules...

February 16, 2022.QUEBEC CITY (BUSINESS WIRE)Saguaro Technologies Inc. announces the closing of a $1.1M start-up financing led by a seasoned biotech investor and including non-dilutive grant funding. “We are pleased to close our first financing...